Fingerprint
Dive into the research topics of 'Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/ daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically